Concourse Financial Group Securities’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5
| Closed | -$1.33K | – | 270 |
|
|
2024
Q4 | $1.33K | Buy |
5
+2
| +67% | +$533 | ﹤0.01% | 2060 |
|
|
2024
Q3 | $825 | Sell |
3
-19
| -86% | -$5.23K | ﹤0.01% | 2093 |
|
|
2024
Q2 | $5.35K | Buy |
22
+1
| +5% | +$243 | ﹤0.01% | 1855 |
|
|
2024
Q1 | $3.14K | Sell |
21
-5
| -19% | -$747 | ﹤0.01% | 1976 |
|
|
2023
Q4 | $4.98K | Buy |
26
+23
| +767% | +$4.4K | ﹤0.01% | 1847 |
|
|
2023
Q3 | $531 | Buy |
+3
| New | +$531 | ﹤0.01% | 2168 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2501 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2525 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2463 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2190 |
|
|
2022
Q2 | – | Sell |
-76
| Closed | -$12K | – | 2339 |
|
|
2022
Q1 | $12K | Buy |
76
+4
| +6% | +$632 | ﹤0.01% | 1625 |
|
|
2021
Q4 | $12K | Buy |
72
+30
| +71% | +$5K | ﹤0.01% | 1793 |
|
|
2021
Q3 | $8K | Sell |
42
-3
| -7% | -$571 | ﹤0.01% | 1933 |
|
|
2021
Q2 | $8K | Buy |
45
+2
| +5% | +$356 | ﹤0.01% | 1916 |
|
|
2021
Q1 | $6K | Buy |
+43
| New | +$6K | ﹤0.01% | 1902 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2404 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2269 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2184 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2266 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2172 |
|
|
2019
Q3 | – | Sell |
-360
| Closed | -$26K | – | 1866 |
|
|
2019
Q2 | $26K | Buy |
360
+200
| +125% | +$14.4K | ﹤0.01% | 1141 |
|
|
2019
Q1 | $14K | Buy |
+160
| New | +$14K | ﹤0.01% | 1381 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2215 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1749 |
|